AEON BIOPHARMA INC
CL A · CUSIP 00791X100
0
institutional holders
-38 vs Q4 2024
—reported value*
0 new
0 added
0 reduced
38 sold out
net sold ≈ $4.8m (-8.9m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2023 | 16 |
| Q4 2023 | 21 |
| Q1 2024 | 28 |
| Q2 2024 | 26 |
| Q3 2024 | 31 |
| Q4 2024 | 38 |
| Q1 2025 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 11 | 4 |
| Q1 2024 | 18 | 4 |
| Q2 2024 | 12 | 12 |
| Q3 2024 | 18 | 9 |
| Q4 2024 | 16 | 11 |
| Q1 2025 | 0 | 38 |
Biggest buyers
| None |
Biggest sellers
| Blue Owl Capital Holdings LP | Sold out | -3.0m |
| Polar Asset Management Partners Inc. | Sold out | -2.8m |
| VANGUARD GROUP INC | Sold out | -749.1k |
| Formidable Asset Management, LLC | Sold out | -689.2k |
| BlackRock, Inc. | Sold out | -265.5k |
| Ikarian Capital, LLC | Sold out | -257.6k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -251.8k |
| BANK OF AMERICA CORP /DE/ | Sold out | -166.6k |
| Caprock Group, LLC | Sold out | -62.7k |
| STATE STREET CORP | Sold out | -61.0k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| BIGGER CAPITAL FUND L P 13G · passive investor new · filed 2025-01-08 | 6.1% |
| PALMISANO ROBERT J 13D · may seek influence no change · filed 2025-03-07 | 5.7% |
Holders, Q1 2025
| Manager | Shares | Change |
|---|